{"protocolSection": {"identificationModule": {"nctId": "NCT02170532", "orgStudyIdInfo": {"id": "Pro00013822"}, "organization": {"fullName": "Duke University", "class": "OTHER"}, "briefTitle": "Aerosolized Beta-Agonist Isomers in Asthma", "officialTitle": "Aerosolized Beta-Agonist Isomers in Asthma"}, "statusModule": {"statusVerifiedDate": "2014-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-07"}, "primaryCompletionDateStruct": {"date": "2009-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-06-19", "studyFirstSubmitQcDate": "2014-06-19", "studyFirstPostDateStruct": {"date": "2014-06-23", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-07-10", "resultsFirstSubmitQcDate": "2014-07-10", "resultsFirstPostDateStruct": {"date": "2014-08-04", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2014-08-11", "lastUpdatePostDateStruct": {"date": "2014-08-13", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Duke University", "class": "OTHER"}}, "descriptionModule": {"briefSummary": "Dr. MacIntyre and his colleagues are studying inhaled medications in asthma. There are two new medications that have been approved by the United States Food and Drug Administration (FDA): levalbuterol and formoterol. Both of these drugs are similar to standard asthma bronchodilator drugs but offer theoretical advantages in terms of fewer side effects. There are also newer devices to deliver these medications into the lungs: breath actuated nebulizers (BANs) and non-static chambers (Aerochamber-max) that can be used with metered dose inhalers (MDIs or \"puffers\"). The purpose of this study is to deliver these new medications using several different devices and measuring lung function, heart rate, and sensations of breathlessness.", "detailedDescription": "Patients will be studied on five separate mornings. The duration of the study and frequency of the visits will be solely dependant on the subject availability. Each subject will receive all 5 treatments in the same order."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 10, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "levalbuterol + saline in a breath actuated nebulizer", "type": "ACTIVE_COMPARATOR", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer", "interventionNames": ["Drug: levalbuterol", "Drug: saline", "Device: breath actuated nebulizer"]}, {"label": "levalbuterol + ipratroprium in a breath actuated nebulizer", "type": "ACTIVE_COMPARATOR", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer", "interventionNames": ["Drug: levalbuterol", "Device: breath actuated nebulizer", "Drug: ipratroprium"]}, {"label": "levalbuterol MDI 2 puffs", "type": "ACTIVE_COMPARATOR", "description": "levalbuterol metered dose inhaler 2 puffs", "interventionNames": ["Other: levalbuterol MDI"]}, {"label": "levalbuterol MDI + aerochamber max without pause 2 puffs", "type": "ACTIVE_COMPARATOR", "description": "levalbuterol MDI + aerochamber max without pause 2 puffs", "interventionNames": ["Other: levalbuterol MDI", "Device: aerochamber max"]}, {"label": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs", "type": "ACTIVE_COMPARATOR", "description": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs", "interventionNames": ["Other: levalbuterol MDI", "Device: aerochamber max"]}], "interventions": [{"type": "DRUG", "name": "levalbuterol", "description": "0.5 ml. levalbuterol", "armGroupLabels": ["levalbuterol + ipratroprium in a breath actuated nebulizer", "levalbuterol + saline in a breath actuated nebulizer"]}, {"type": "DRUG", "name": "saline", "description": "0.5ml saline", "armGroupLabels": ["levalbuterol + saline in a breath actuated nebulizer"]}, {"type": "OTHER", "name": "levalbuterol MDI", "armGroupLabels": ["levalbuterol MDI + aerochamber max with 2 second pause 2 puffs", "levalbuterol MDI + aerochamber max without pause 2 puffs", "levalbuterol MDI 2 puffs"]}, {"type": "DEVICE", "name": "breath actuated nebulizer", "armGroupLabels": ["levalbuterol + ipratroprium in a breath actuated nebulizer", "levalbuterol + saline in a breath actuated nebulizer"]}, {"type": "DEVICE", "name": "aerochamber max", "armGroupLabels": ["levalbuterol MDI + aerochamber max with 2 second pause 2 puffs", "levalbuterol MDI + aerochamber max without pause 2 puffs"]}, {"type": "DRUG", "name": "ipratroprium", "armGroupLabels": ["levalbuterol + ipratroprium in a breath actuated nebulizer"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Maximum Forced Expiratory Volume at One Second (FEV1)", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment"}], "secondaryOutcomes": [{"measure": "Change in 8 Hour Area-under-the-curve FEV1", "timeFrame": "0 to 8 hours post dose"}, {"measure": "Change in Heart Rate", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment"}, {"measure": "Change in Tremor Assessment Measured by a Scale", "description": "Tremor assessment will be made on outstretched hands (0 = none, 1+ = fine tremor, barely perceptible, 2+ = obvious tremor).", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment"}, {"measure": "Change in Dyspnea Response as Measured by the University of California, San Diego (UCSD) Dyspnea Scale", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* stable mild to moderate persistent asthma as defined by the National Asthma Education and Prevention Program\n* greater than 18 years of age\n* requiring bronchodilator therapy either routinely or on a as needed (PRN)basis\n* stable with respect to respiratory disease and at least four weeks removed from the most recent acute exacerbation of the disease\n* patients may or may not be on inhaled corticosteroids\n\nExclusion Criteria:\n\n* no unstable cardiovascular symptoms\n* no unstable angina\n* must be at least four weeks removed from an acute coronary syndrome", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Neil MacIntyre, MD", "affiliation": "Duke University", "role": "PRINCIPAL_INVESTIGATOR"}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "All Subjects", "description": "All subjects will receive all 5 treatments on 5 different treatment days. Each subject will receive all 5 treatments in the same order."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "All subjects will receive all 5 treatments on 5 different treatment days. Each subject will receive all 5 treatments in the same order.", "groups": [{"id": "BG000", "title": "All Subjects", "description": "All subjects will receive all 5 treatments on 5 different treatment days. Each subject will receive all 5 treatments in the same order."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "10"}]}], "measures": [{"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "18 & older", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "6"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "4"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Maximum Forced Expiratory Volume at One Second (FEV1)", "populationDescription": "The same 10 subjects received each of the 5 treatments in the same order. Subjects 1-5 were not included in 6 and 8 hour time points.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of change", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment", "groups": [{"id": "OG000", "title": "Levalbuterol + Saline in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nsaline: 0.5ml saline\n\nbreath actuated nebulizer"}, {"id": "OG001", "title": "Levalbuterol + Ipratroprium in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nbreath actuated nebulizer\n\nipratroprium"}, {"id": "OG002", "title": "Levalbuterol Metered Dose Inhaler (MDI) 2 Puffs", "description": "levalbuterol metered dose inhaler (MDI) 2 puffs\n\nlevalbuterol MDI"}, {"id": "OG003", "title": "Levalbuterol MDI + Aerochamber Max Without Pause 2 Puffs", "description": "levalbuterol metered-dose inhaler (MDI) + aerochamber max without pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}, {"id": "OG004", "title": "Levalbuterol MDI + Aerochamber Max With 2 Second Pause 2 Puffs", "description": "levalbuterol metered dose inhaler (MDI) + aerochamber max with 2 second pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "10"}, {"groupId": "OG004", "value": "10"}]}], "classes": [{"title": "30 minutes", "categories": [{"measurements": [{"groupId": "OG000", "value": "20", "spread": "23.19"}, {"groupId": "OG001", "value": "20", "spread": "16.55"}, {"groupId": "OG002", "value": "20", "spread": "19.85"}, {"groupId": "OG003", "value": "19", "spread": "20.64"}, {"groupId": "OG004", "value": "21", "spread": "21.10"}]}]}, {"title": "1 hour", "categories": [{"measurements": [{"groupId": "OG000", "value": "28", "spread": "31.45"}, {"groupId": "OG001", "value": "23", "spread": "19.24"}, {"groupId": "OG002", "value": "19", "spread": "22.57"}, {"groupId": "OG003", "value": "20", "spread": "24.23"}, {"groupId": "OG004", "value": "24", "spread": "22.62"}]}]}, {"title": "2 hour", "categories": [{"measurements": [{"groupId": "OG000", "value": "26", "spread": "32.23"}, {"groupId": "OG001", "value": "22", "spread": "20.64"}, {"groupId": "OG002", "value": "20", "spread": "23.02"}, {"groupId": "OG003", "value": "19", "spread": "26.25"}, {"groupId": "OG004", "value": "19", "spread": "21.47"}]}]}, {"title": "4 hour", "categories": [{"measurements": [{"groupId": "OG000", "value": "15", "spread": "29.05"}, {"groupId": "OG001", "value": "14", "spread": "18.89"}, {"groupId": "OG002", "value": "7", "spread": "18.99"}, {"groupId": "OG003", "value": "6", "spread": "16.88"}, {"groupId": "OG004", "value": "7", "spread": "18.51"}]}]}, {"title": "6 hour", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "18.9"}, {"groupId": "OG001", "value": "1", "spread": "5.23"}, {"groupId": "OG002", "value": "-5", "spread": "5.98"}, {"groupId": "OG003", "value": "1", "spread": "16.05"}, {"groupId": "OG004", "value": "-6", "spread": "11.68"}]}]}, {"title": "8 hour", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "21.26"}, {"groupId": "OG001", "value": "9", "spread": "13.10"}, {"groupId": "OG002", "value": "-3", "spread": "7.91"}, {"groupId": "OG003", "value": "0", "spread": "15.54"}, {"groupId": "OG004", "value": "-6", "spread": "11.55"}]}]}]}, {"type": "SECONDARY", "title": "Change in 8 Hour Area-under-the-curve FEV1", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percentage of change", "timeFrame": "0 to 8 hours post dose", "groups": [{"id": "OG000", "title": "Levalbuterol + Saline in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nsaline: 0.5ml saline\n\nbreath actuated nebulizer"}, {"id": "OG001", "title": "Levalbuterol + Ipratroprium in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nbreath actuated nebulizer\n\nipratroprium"}, {"id": "OG002", "title": "Levalbuterol MDI 2 Puffs", "description": "levalbuterol metered dose inhaler 2 puffs\n\nlevalbuterol MDI"}, {"id": "OG003", "title": "Levalbuterol MDI + Aerochamber Max Without Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max without pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}, {"id": "OG004", "title": "Levalbuterol MDI + Aerochamber Max With 2 Second Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "10"}, {"groupId": "OG003", "value": "10"}, {"groupId": "OG004", "value": "10"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5450", "spread": "7039"}, {"groupId": "OG001", "value": "4729", "spread": "4275"}, {"groupId": "OG002", "value": "3893", "spread": "4949"}, {"groupId": "OG003", "value": "3805", "spread": "5253"}, {"groupId": "OG004", "value": "4195", "spread": "4795"}]}]}]}, {"type": "SECONDARY", "title": "Change in Heart Rate", "populationDescription": "Data for this outcome measure is not reported because the data was not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment", "groups": [{"id": "OG000", "title": "Levalbuterol + Saline in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nsaline: 0.5ml saline\n\nbreath actuated nebulizer"}, {"id": "OG001", "title": "Levalbuterol + Ipratroprium in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nbreath actuated nebulizer\n\nipratroprium"}, {"id": "OG002", "title": "Levalbuterol MDI 2 Puffs", "description": "levalbuterol metered dose inhaler 2 puffs\n\nlevalbuterol MDI"}, {"id": "OG003", "title": "Levalbuterol MDI + Aerochamber Max Without Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max without pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}, {"id": "OG004", "title": "Levalbuterol MDI + Aerochamber Max With 2 Second Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Change in Tremor Assessment Measured by a Scale", "description": "Tremor assessment will be made on outstretched hands (0 = none, 1+ = fine tremor, barely perceptible, 2+ = obvious tremor).", "populationDescription": "Data for this outcome measure is not reported because the data was not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment", "groups": [{"id": "OG000", "title": "Levalbuterol + Saline in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nsaline: 0.5ml saline\n\nbreath actuated nebulizer"}, {"id": "OG001", "title": "Levalbuterol + Ipratroprium in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nbreath actuated nebulizer\n\nipratroprium"}, {"id": "OG002", "title": "Levalbuterol MDI 2 Puffs", "description": "levalbuterol metered dose inhaler 2 puffs\n\nlevalbuterol MDI"}, {"id": "OG003", "title": "Levalbuterol MDI + Aerochamber Max Without Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max without pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}, {"id": "OG004", "title": "Levalbuterol MDI + Aerochamber Max With 2 Second Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Change in Dyspnea Response as Measured by the University of California, San Diego (UCSD) Dyspnea Scale", "populationDescription": "Data for this outcome measure is not reported because the data was not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline (before treatment), 30 minutes, 1, 2, 4, 6, and 8 hours post treatment", "groups": [{"id": "OG000", "title": "Levalbuterol + Saline in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml saline in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nsaline: 0.5ml saline\n\nbreath actuated nebulizer"}, {"id": "OG001", "title": "Levalbuterol + Ipratroprium in a Breath Actuated Nebulizer", "description": "0.5 ml. levalbuterol + 0.5ml ipratroprium in a breath actuated nebulizer\n\nlevalbuterol: 0.5 ml. levalbuterol\n\nbreath actuated nebulizer\n\nipratroprium"}, {"id": "OG002", "title": "Levalbuterol MDI 2 Puffs", "description": "levalbuterol metered dose inhaler 2 puffs\n\nlevalbuterol MDI"}, {"id": "OG003", "title": "Levalbuterol MDI + Aerochamber Max Without Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max without pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}, {"id": "OG004", "title": "Levalbuterol MDI + Aerochamber Max With 2 Second Pause 2 Puffs", "description": "levalbuterol MDI + aerochamber max with 2 second pause 2 puffs\n\nlevalbuterol MDI\n\naerochamber max"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "All Subjects", "description": "All subjects will receive all 5 treatments on 5 different treatment days. Each subject will receive all 5 treatments in the same order.", "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 0, "otherNumAtRisk": 10}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Neil MacIntyre, MD", "organization": "Duke University Medical Center", "email": "macin001@mc.duke.edu", "phone": "(919) 681-2720"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000000420", "term": "Albuterol"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "asFound": "APD", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}